Correlation risk analysis of serum RAGE and HLI levels in patients with immune diseases
Journal of Medical Biochemistry · Published 2026-01-01 · DOI 10.5937/jomb0-63985
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.5937/jomb0-63985
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- A novel multi-analyte serum panel combining CA-125, HE4, microrna-200a, and interleukin-6 for the preclinical detection of high-grade serous ovarian carcinoma in women with pathogenic BRCA1/2 variants · Journal of Medical Biochemistry · 2026 · Same journal
- Applicability of LDL-cholesterol calculation formulas in hypertriglyceridemia: Insights from the Vojvodina · Journal of Medical Biochemistry · 2026 · Same journal
- Correlation analysis of serum CRK, CD138, and APL with the prognosis of patients with diabetic nephropathy · Journal of Medical Biochemistry · 2026 · Same journal
- A tripartite biomarker panel of systemic inflammation, immune activation, and tubular injury (IL-6, suPAR, KIM-1) predicts mortality and cardiovascular outcomes in end-stage renal disease · Journal of Medical Biochemistry · 2026 · Same journal
- Diagnostic value of combined serum protein carbonyl, 8-hydroxy-2'-deoxyguanosine, and PGC-1a detection for myocardial energy metabolism disorder in ischemic cardiomyopathy · Journal of Medical Biochemistry · 2026 · Same journal
- Novel serum biomarkers, medication adherence, and a predictive nomogram in patients with type 2 diabetes and ischemic stroke · Journal of Medical Biochemistry · 2026 · Same journal
- Cardiometabolic parameters and novel hematological indices in women with migraine · Journal of Medical Biochemistry · 2026 · Same journal
- Correlation analysis of Serum CD354 and ANGPT2 levels with the prognosis of sepsis · Journal of Medical Biochemistry · 2026 · Same journal
- Serum cytokine panel predicts cardiac outcomes following acute myocardial infarction · Journal of Medical Biochemistry · 2026 · Same journal
- Novel serum biomarkers for real-time treatment monitoring and prognostication in hepatocellular carcinoma patients · Journal of Medical Biochemistry · 2026 · Same journal